-
Skin Cancer
56
global
1
0.75
2
0.75
3
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-09-28 20:00:00
Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer (NMSC)?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Skin Cancer
56
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Hematology-Oncology2023-09-27 20:00:00
Did you know that the multidisciplinary team is key when considering systemic immunotherapy for patients with nonmelanoma skin cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Rheumatoid Arthritis
83
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Rheumatology2023-09-24 20:00:00
Are you up to date on the latest evidence regarding the use of Janus kinase (JAK) inhibitors in inflammatory joint diseases?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Urticaria and Angioedema
6006612
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Dermatology2023-08-30 20:00:00
Get up to date on managing patients with chronic spontaneous urticaria (CSU) in this fast-paced program!
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Melanoma
65
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-08-22 20:00:00
Do you want to contribute to more equitable melanoma care? Find out how you can do more for your patients in this informative activity.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
0.5
2
0.5
0.5
Roundtable
0
1
Dermatology2023-08-14 20:00:00
What are your patients’ goals for vitiligo treatment?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Skin Cancer
56
global
1
0.75
2
0.75
3
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-09-28 20:00:00
Do you know your role on the healthcare team in the care of patients with nonmelanoma skin cancer (NMSC)?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Revenue and Practice Management
3029345
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Brief
0
1
Family Medicine/Primary Care2023-09-29 00:00:00
Learn about the latest developments in family medicine: alopecia areata, glaucoma, and breast cancer.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Skin Cancer
56
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Hematology-Oncology2023-09-27 20:00:00
Did you know that the multidisciplinary team is key when considering systemic immunotherapy for patients with nonmelanoma skin cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Social Determinants of Health
6010999
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Review
0
2
Hematology-Oncology2023-09-28 00:00:00
Do you know how to talk to your patients about cancer care costs?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Rheumatoid Arthritis
83
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Rheumatology2023-09-24 20:00:00
Are you up to date on the latest evidence regarding the use of Janus kinase (JAK) inhibitors in inflammatory joint diseases?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
0
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Brief
0
1
Family Medicine/Primary Care2023-09-06 00:00:00
Substance abuse, allergens, and the implications of child assault on mental health – what does the latest evidence tell us?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Urticaria and Angioedema
6006612
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Dermatology2023-08-30 20:00:00
Get up to date on managing patients with chronic spontaneous urticaria (CSU) in this fast-paced program!
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Melanoma
65
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-08-22 20:00:00
Do you want to contribute to more equitable melanoma care? Find out how you can do more for your patients in this informative activity.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
0.5
2
0.5
0.5
Roundtable
0
1
Dermatology2023-08-14 20:00:00
What are your patients’ goals for vitiligo treatment?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Dermatitis
8
global
1
1.0
9
1.0
1.0
Roundtable
0
1
Dermatology2023-08-08 20:00:00
Are you up to date about emerging biologics in moderate to severe atopic dermatitis (AD)?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Crohn Disease
1679
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Dermatology2023-08-03 20:00:00
A new study examines the prevalence of Crohn disease in a large cohort of adolescents with hidradenitis suppurativa.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Skin Cancer
56
global
1
0.25
9
0.25
2
0.25
3
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-08-01 20:00:00
Did you know that BRAF class II/III alterations comprise more than half of oncogenic BRAF alterations?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Myelodysplastic Syndrome
1557
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Hematology-Oncology2023-07-20 20:00:00
UBA1mut cells are the main cause of systemic inflammation/marrow failure in VEXAS, a new molecularly defined somatic entity linked to myelodysplastic syndrome (MDS).
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Biologic Therapy
5000033
global
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-07-06 20:00:00
Do you know how the biosafety risks of oncolytic immunotherapies and their combination with immune checkpoint inhibitors can be mitigated?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Spondylitis, Spondylosis, Kyphosis
118
us
1
0.25
9
0.25
0.25
Roundtable
0
1
Rheumatology2023-06-29 20:00:00
What are appropriate treatment goals to achieve disease suppression in your patients with spondyloarthritis?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
0
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Dermatology2023-06-28 20:00:00
How are you recommending over-the-counter skincare to your patients with cutaneous adverse events?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Dermatitis
8
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Dermatology2023-06-22 20:00:00
A new study highlights the association between an Internet-based stress reduction intervention on quality of life for patients with atopic dermatitis.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Acne
38
global
1
1.0
9
1.0
2
1.0
3
1.0
1.0
Commentary
0
1
Pediatrics2023-06-22 20:00:00
Do you know how to negotiate potential pediatric skin challenges with your patients and their parents?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
